Tirzepatide uses a structured dose escalation schedule, starting low and increasing gradually, to minimize side effects while building to the dose that produces the strongest outcomes. Here's the standard protocol and what you need to know at each stage.
Standard Tirzepatide Dosing Schedule
| Week | Dose | Purpose |
|---|---|---|
| Weeks 1–4 | 2.5 mg weekly | Tolerability initiation |
| Weeks 5–8 | 5 mg weekly | First therapeutic dose |
| Weeks 9–12 | 7.5 mg weekly | Increasing effect |
| Weeks 13–16 | 10 mg weekly | Continued escalation |
| Weeks 17–20 | 12.5 mg weekly | Near maximum dose |
| Week 21+ | 15 mg weekly | Maximum dose (maintenance) |
This is the schedule from the Zepbound (tirzepatide) FDA label. Telehealth providers may use slightly modified schedules based on individual tolerance and response.
The Starting Dose: 2.5 mg
The 2.5mg starting dose is for tolerability, it's not effective enough for significant weight loss but allows your body to adjust to the medication's GI effects. Many patients experience nausea, some experience vomiting, during this phase. It typically improves significantly within the first 2–4 weeks.
Do not try to accelerate past the starting dose because side effects seem mild. The dose escalation schedule is designed to build tolerance progressively.
When to Slow Escalation
If you're experiencing significant side effects, vomiting, severe nausea, diarrhea, at a given dose, stay at that dose for an additional 4 weeks before moving up. This is not failure; it's appropriate management. Most telehealth providers allow dose hold requests through their messaging platform.
Signs to hold a dose escalation:
- Vomiting more than 2–3 times per week
- Nausea that significantly affects daily activities
- Diarrhea that hasn't resolved within 2 weeks at current dose
- Significant abdominal discomfort
Not Everyone Needs 15 mg
The clinical trials showed dose-dependent outcomes, higher doses produce more weight loss on average. But the 5mg and 10mg doses also produce significant weight loss for many patients. Some patients achieve excellent results at lower doses with fewer side effects. Maximum dose isn't always necessary or optimal for every individual.
Injection Technique
Tirzepatide from telehealth providers comes as a multi-dose vial. You draw the prescribed volume into a small insulin syringe (typically 0.05–0.1mL depending on dose) and inject subcutaneously. Rotate injection sites between abdomen, thigh, and upper arm. Use a new needle each time. Inject on the same day each week.
Compounded Dosing vs. Brand Dosing
Compounded tirzepatide and brand-name Zepbound contain the same active ingredient. Compounded versions typically come in a vial with a specified concentration (e.g., 5mg/mL or 10mg/mL), your provider will specify the volume to draw for each dose. This is equivalent to the brand-name dosing in terms of the active drug delivered.